FDC

When is the next results date for FDC?

No Upcoming Board Meetings

Who are in the management team of FDC?

As of March 2022, the management team of FDC includes Mohan A Chandavarkar (Managing Director), Ashok A Chandavarkar (Director), Nandan M Chandavarkar (Joint Managing Director), Ameya A Chandavarkar (Executive Director & CEO), and several independent and non-executive directors, ensuring diverse governance and strategic direction.

As of March 2022, the management team of FDC includes:<BR><BR>1. Mohan A Chandavarkar - Managing Director<BR>2. Ashok A Chandavarkar - Director<BR>3. Nandan M Chandavarkar - Joint Managing Director<BR>4. Ameya A Chandavarkar - Executive Director & CEO<BR>5. Ramdas A Chandavarkar - Chairman Emeritus<BR>6. Varsharani Katre - Company Secretary & Compliance Officer<BR>7. Nomita R Chandavarkar - Director<BR>8. Swati S Mayekar - Independent Director<BR>9. Uday Kumar Gurkar - Chairman & Independent Director<BR>10. Melarkode Ganesan Parameswaran - Independent Director<BR>11. Usha Athreya Chandrasekhar - Independent Director<BR>12. Mahesh Bijlani - Independent Director<BR>13. Vijay Maniar - Additional Independent Director<BR><BR>This team comprises a mix of executive, independent, and non-executive directors, contributing to the governance and strategic direction of the company.

What does FDC do?

FDC Ltd is a mid-cap, research-oriented pharmaceutical company in India that manufactures and markets formulations and active pharmaceutical ingredients. As of March 2025, it reported net sales of ₹492 Cr and a net profit of ₹39 Cr, with a market cap of ₹7,004 Cr.

Overview: <BR>FDC Ltd is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients, operating within the Pharmaceuticals & Biotechnology industry as a mid-cap entity.<BR><BR>History: <BR>FDC Ltd was incorporated in an unspecified year and has maintained its status as a prominent player in the Indian pharmaceutical industry. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 492 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 39 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 7,004 Cr (Mid Cap) <BR><BR>Key Metrics: <BR>P/E: 26.00 <BR>Industry P/E: 35 <BR>Dividend Yield: 1.15% <BR>Debt-Equity: -0.23 <BR>Return on Equity: 11.70% <BR>Price to Book: 3.10 <BR><BR>Contact Details: <BR>Address: B-8 MIDC Industrial Area, Waluj Dist Aurangabad (Maharashtra) Maharashtra : 431136 <BR>Phone: 91-240-2554407/967/299 <BR>Email: investors@fdcindia.com <BR>Website: http://www.fdcindia.com

Has FDC declared dividend?

FDC Ltd has declared a 500% dividend, amounting to ₹5 per share, with an ex-date of November 22, 2024. While recent returns have shown volatility, the company has demonstrated positive growth over the longer term, particularly in the 2 to 5-year periods.

FDC Ltd has declared a 500% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 500%<BR>- Amount per share: 5 per share<BR>- Ex-date: 22 Nov 24<BR><BR>Dividend Yield: 1.15%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -16.29%, with a dividend return of 0%, resulting in a total return of -16.29%.<BR><BR>Over the past year, the price return was -1.42%, the dividend return was 1.11%, leading to a total return of -0.31%.<BR><BR>In the 2-year period, the price return was 45.65%, the dividend return was 1.62%, culminating in a total return of 47.27%.<BR><BR>For the 3-year period, the price return was 75.79%, the dividend return was 2.16%, resulting in a total return of 77.95%.<BR><BR>In the last 4 years, the price return was 27.43%, the dividend return was 1.40%, leading to a total return of 28.83%.<BR><BR>Over the past 5 years, the price return was 64.51%, the dividend return was 1.86%, culminating in a total return of 66.37%.<BR><BR>Overall, FDC Ltd has declared a significant dividend, and while recent returns show some volatility, the longer-term performance indicates positive growth, particularly over the 2 to 5-year periods.

Who are the peers of the FDC?

FDC's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, SPARC, Supriya Lifesci, Innova Captab, Sequent Sciences, and Hikal. FDC has average management risk and below average growth compared to its peers, with a 1-year return of 1.55%.

Peers: The peers of FDC are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, SPARC, Supriya Lifesci., Innova Captab, Sequent Scien., and Hikal.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Supriya Lifesci., while Good management risk is found at Divi's Lab., Torrent Pharma, and Innova Captab. Average management risk is present at FDC, Sequent Scien., and Hikal, while Below Average management risk is noted for SPARC. Growth is Excellent for Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Innova Captab, while Below Average growth is seen at Divi's Lab., Torrent Pharma, FDC, SPARC, Supriya Lifesci., and Hikal. The rest have Good growth. Excellent capital structure is noted for Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, FDC, Supriya Lifesci., and Innova Captab, while Good capital structure is found at Torrent Pharma, Average at Hikal, and Below Average at SPARC and Sequent Scien.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Supriya Lifesci. at 101.03%, while the lowest is SPARC at -7.92%. FDC's own 1-year return is 1.55%, which is significantly lower than the highest and higher than the lowest. Additionally, the peers with negative six-month returns include FDC, SPARC, and Hikal.

Is FDC overvalued or undervalued?

As of March 5, 2025, FDC is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 26.12 and a year-to-date return of -12.40%, compared to the Sensex's 5.59%.

As of 5 March 2025, the valuation grade for FDC has moved from fair to expensive, indicating that the company is currently overvalued. The key ratios supporting this assessment include a PE ratio of 26.12, an EV to EBITDA of 20.33, and a Price to Book Value of 3.05. Compared to its peers, FDC's valuation appears high; for instance, Sun Pharma has a PE ratio of 35.25, while Cipla, considered attractive, has a PE of 22.99.<BR><BR>In light of these metrics, FDC is deemed overvalued relative to its industry peers. The company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -12.40% compared to the Sensex's 5.59%, further reinforcing the notion that the stock may not be a favorable investment at its current price of 434.75.

Who are the top shareholders of the FDC?

The top shareholders of FDC include promoter Nomita R Chandavarkar with 22.67%, mutual funds at 6.18%, foreign institutional investors at 2.55%, and individual investors collectively owning 16.22%. The largest public shareholder is the ICICI Prudential Smallcap Fund, holding 2.87%.

The top shareholders of FDC include the promoters, who hold the majority of the shares. The promoter with the highest holding is Nomita R Chandavarkar, owning 22.67% of the company. In addition, mutual funds hold 6.18% of the shares through 10 different schemes, while foreign institutional investors (FIIs) hold 2.55% through 105 different entities. The highest public shareholder is the ICICI Prudential Smallcap Fund, which holds 2.87%. Individual investors collectively own 16.22% of the company.

How big is FDC?

As of 24th July, FDC Ltd has a market capitalization of 7,983.00 Cr, with recent net sales of 2,108.12 Cr and net profit of 266.79 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: FDC Ltd has a market capitalization of 7,983.00 Cr and is classified as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 2,108.12 Cr, while the sum of Net Profit for the same period is 266.79 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 2,097.17 Cr and Total Assets valued at 2,468.09 Cr.

How has been the historical performance of FDC?

FDC has shown consistent growth in net sales, increasing from 1,090.70 Cr in Mar'19 to 2,108.12 Cr in Mar'25, while total assets rose to 2,713.80 Cr. However, profit margins and earnings per share have experienced volatility, with EPS declining from 18.75 in Mar'24 to 16.39 in Mar'25.

Answer:<BR>The historical performance of FDC shows a consistent growth trend in net sales and overall financial metrics over the years.<BR><BR>Breakdown:<BR>FDC's net sales have increased from 1,090.70 Cr in Mar'19 to 2,108.12 Cr in Mar'25, reflecting a steady growth trajectory. The total operating income has similarly risen, reaching 2,108.12 Cr in Mar'25 from 1,090.70 Cr in Mar'19. However, the total expenditure has also grown, amounting to 1,783.32 Cr in Mar'25, up from 859.68 Cr in Mar'19. Operating profit (PBDIT) has fluctuated, peaking at 440.17 Cr in Mar'24 before dropping to 415.46 Cr in Mar'25. Profit before tax reached 357.22 Cr in Mar'25, while profit after tax was recorded at 266.79 Cr. The earnings per share (EPS) decreased from 18.75 in Mar'24 to 16.39 in Mar'25, indicating a decline despite the growth in sales. On the balance sheet, total assets increased from 1,812.93 Cr in Mar'20 to 2,713.80 Cr in Mar'25, with total liabilities also rising to 2,713.80 Cr in Mar'25. Cash flow from operating activities improved significantly to 317.00 Cr in Mar'25 from 220.00 Cr in Mar'24, contributing to a net cash inflow of 26.00 Cr in Mar'25. Overall, FDC has demonstrated growth in sales and assets, although profit margins and EPS have shown some volatility.

Is FDC technically bullish or bearish?

As of November 18, 2025, FDC's technical trend has shifted to a moderate bearish stance, driven by bearish MACD, moving averages, and Bollinger Bands, despite a conflicting bullish signal from the OBV on the monthly timeframe.

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for FDC is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from Bollinger Bands on both weekly and monthly timeframes. The KST is also bearish on the weekly, reinforcing the negative outlook. Although the OBV shows a bullish signal on the monthly, it does not outweigh the overall bearish indicators.

Are FDC Ltd latest results good or bad?

FDC Ltd's latest results are concerning, with a 23.60% decline in net profit and a significant drop in operating profit margin to 11.25%. The reliance on non-operating income for 36.38% of profit before tax further highlights challenges in core business performance, indicating a negative outlook for the company.

FDC Ltd's latest results indicate significant challenges for the company. In the third quarter of FY26, the net profit was ₹28.30 crore, reflecting a substantial decline of 23.60% year-on-year. Although revenue showed a slight increase of 0.13% year-on-year, it experienced a sequential decline of 1.76% compared to the previous quarter.<BR><BR>One of the most alarming aspects of the results is the operating profit margin, which fell drastically to 11.25% from 22.97% in the same quarter last year, marking a decline of 11.72 percentage points. This margin erosion raises serious concerns about the company's operational efficiency and sustainability in the competitive pharmaceutical landscape.<BR><BR>Moreover, a significant portion of the profit before tax—36.38%—was derived from other income, highlighting a dependency on non-operating income rather than core business performance. This reliance is a red flag, suggesting that the company is struggling to generate adequate returns from its primary operations.<BR><BR>Overall, the financial performance points to a company facing substantial operational challenges, with deteriorating margins and profitability metrics. The outlook appears cautious, and the results can be characterized as negative, raising concerns about FDC's future prospects.

Should I buy, sell or hold FDC Ltd?

Why is FDC Ltd falling/rising?

As of 30-Apr, FDC Ltd's stock price is rising to 364.70, but it faces significant long-term challenges, including a -4.35% decline in annual operating profit over five years and a -13.21% return over the past year, alongside decreased investor participation.

As of 30-Apr, FDC Ltd's stock price is rising, currently at 364.70, with a change of 0.95 (0.26%) increase. This upward movement follows a trend reversal after two consecutive days of decline. The stock has outperformed its sector by 1.29% today, indicating a positive shift in performance relative to its peers.<BR><BR>Despite the recent rise, the stock has shown poor long-term growth, with an annual operating profit decline of -4.35% over the last five years. Additionally, the company reported negative results for December 25, with a significant drop in profit before tax (PBT) and profit after tax (PAT) compared to previous quarters. The return on capital employed (ROCE) is at its lowest, and the stock is trading at a premium compared to its peers, with a price-to-book value of 2.5.<BR><BR>Investor participation has also decreased, with delivery volume falling by -73.59% against the five-day average, which may indicate a lack of confidence among investors. Furthermore, the stock has generated a return of -13.21% over the past year, reflecting its underperformance in both the near and long term.<BR><BR>In summary, while FDC Ltd's stock is currently rising, this is juxtaposed against a backdrop of significant long-term challenges and declining investor interest.

Which are the latest news on FDC?